Teva ' s Barr Labs Settles Cipro Antitrust Case for $225 Mln Teva ' s Barr Labs Settles Cipro Antitrust Case for $225 Mln

Teva Pharmaceutical Industries Ltd ' s Barr Laboratories Inc has reached a $225 million settlement in an antitrust class action that accused the drugmaker of keeping a generic version of Bayer AG ' s antibiotic ciprofloxacin (Cipro) off the market, court documents showed.Reuters Health Information
Source: Medscape Pathology Headlines - Category: Pathology Tags: Pathology & Lab Medicine News Source Type: news